
# Title 21— FOOD AND DRUGS
### CHAPTER 9— FEDERAL FOOD, DRUG, AND COSMETIC ACT
#### § 360bb. Designation of drugs for rare diseases or conditions
##### (b) Notification of discontinuance of drug or application as condition

A designation of a drug under subsection (a) shall be subject to the condition that

(1) if an application was approved for the drug under section 355(b) of this title or a license was issued for the drug under section 262 of title 42 , the manufacturer of the drug will notify the Secretary of any discontinuance of the production of the drug at least one year before discontinuance, and

(2) if an application has not been approved for the drug under section 355(b) of this title or a license has not been issued for the drug under section 262 of title 42 and if preclinical investigations or investigations under section 355(i) of this title are being conducted with the drug, the manufacturer or sponsor of the drug will notify the Secretary of any decision to discontinue active pursuit of approval of an application under section 355(b) of this title or approval of a license under section 262 of title 42 .
